WASHINGTON—On Wednesday, U.S. Sen. Ron Johnson (R-Wis.), along with Sen. Mike Braun (R-Ind.), and Sen. Mike Lee (R-Utah) introduced legislation to protect doctors, patients and prescribers. The Right to Treat Act S. 3670 will reaffirm that no federal agency has the authority to regulate the practice of medicine and that no federal law, rule, or regulation of policy will prohibit or restrict the lawful prescribing or disbursing of any FDA approved drug or Right to Try drug.
Sen. Johnson said, “The pandemic exposed the fact that many doctors no longer call the shots when it comes to treating patients, the COVID Cartel does. The COVID Cartel includes the Biden Administration, federal health agencies, Big PHARMA, mainstream media, and Big Tech. The Right to Treat Act would ensure that federal health agencies return to their proper functions of gathering and providing public health data and regulating drug safety – not telling doctors how to practice medicine. Because federal health agencies sabotaged the early treatment of COVID-19 using widely available and safe generic drugs, an untold number of people needlessly died from COVID-19. Americans and doctors should have the freedom to use fully approved drugs without fear of reprisal. It’s time to once again let doctors be doctors and allow them to fully practice medicine.”
Sen. Braun said, “Doctors, not the federal government, know their patients best. It is critical that they have the freedom to prescribe FDA-approved drugs and treatments that are the most appropriate for their patients.”
Sen. Lee said, “The federal government should not dictate individual medical cases. Patients and their doctors should be able to decide the best course of treatment for themselves, and the government shouldn’t foreclose a primary tool of medical innovation. I’m proud to join Senator Johnson in introducing this bill to protect medical freedom.”
Sen. Johnson has done extensive work highlighting the need for early treatment during COVID-19. In May 2020, he held a roundtable entitled, “COVID-19: How New Information Should Drive Policy.” In November 2020, he held a hearing entitled, “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution.” In December 2020, he held a hearing entitled, “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II.” In January 2022, he held a discussion entitled “COVID-19: A Second Opinion.”
Read more about The Right to Treat Act in The Daily Caller.